I agree that this site is using cookies. You can find further informations here.
X
Katzenstein, TL
16  results:
Search for persons X
?
1

Risk factors during pregnancy and birth‐related complicatio..:

Ørbæk, M ; Thorsteinsson, K ; Moseholm Larsen, E...
HIV Medicine.  21 (2019)  2 - p. 84-95 , 2019
Link: https://doi.org/10.1111/..
 
?
2

Assessment of mode of delivery and predictors of emergency ..:

Ørbæk, M ; Thorsteinsson, K ; Helleberg, M...
HIV Medicine.  18 (2017)  10 - p. 736-747 , 2017
Link: https://doi.org/10.1111/..
 
?
3

Soluble urokinase plasminogen activator receptor (suPAR) is..:

Rasmussen, LJH ; Knudsen, A ; Katzenstein, TL...
HIV Medicine.  17 (2015)  5 - p. 350-357 , 2015
Link: https://doi.org/10.1111/..
 
?
4

Incidence of cervical dysplasia and cervical cancer in wome..:

Thorsteinsson, K ; Ladelund, S ; Jensen-Fangel, S...
HIV Medicine.  17 (2015)  1 - p. 7-17 , 2015
Link: https://doi.org/10.1111/..
 
?
5

Prevention of mother‐to‐child transmission of HIV in Denmar..:

Von Linstow, ML ; Rosenfeldt, V ; Lebech, AM...
HIV Medicine.  11 (2010)  7 - p. 448-456 , 2010
Link: https://doi.org/10.1111/..
 
?
6

Zidovudine monotherapy in pregnancy: is it state of the art..:

Katzenstein, TL ; Gerstoft, J
HIV Medicine.  9 (2008)  7 - p. 445-447 , 2008
Link: https://doi.org/10.1111/..
 
?
7

Resistance profiles and adherence at primary virological fa..:

Røge, BT ; Barfod, TS ; Kirk, O...
HIV Medicine.  5 (2004)  5 - p. 344-351 , 2004
Link: https://doi.org/10.1111/..
 
?
8

Virological and immunological profiles among patients with ..:

Katzenstein, TL ; Ullum, H ; Røge, BT...
HIV Medicine.  4 (2003)  1 - p. 53-61 , 2003
Link: https://doi.org/10.1046/..
 
?
9

Drug resistance mutations and outcome of second‐line treatm..:

Røge, BT ; Katzenstein, TL ; Nielsen, HL.
HIV Medicine.  4 (2003)  1 - p. 38-47 , 2003
Link: https://doi.org/10.1046/..
 
?
10

Clinical lipoatrophy in HIV‐1 patients on HAART is not asso..:

Worm, D ; Kirk, O ; Andersen, O...
HIV Medicine.  3 (2002)  4 - p. 239-246 , 2002
Link: https://doi.org/10.1046/..
 
?
11

Low body weight and type of protease inhibitor predict disc..:

Kirk, O ; Gerstoft, J ; Pedersen, C...
HIV Medicine.  2 (2001)  1 - p. 43-51 , 2001
Link: https://doi.org/10.1046/..
 
?
12

Risk factors during pregnancy and birth-related complicatio..:

Ørbæk, M ; Thorsteinsson, K ; Moseholm Larsen, E...
https://vbn.aau.dk/da/publications/67d31156-7ca4-41fd-92d6-bff00c3defd7.  , 2020
Link: https://vbn.aau.dk/da/pu..
 
?
13

Living with cystic fibrosis – a qualitative study of a life..:

Knudsen KB ; Boisen KA ; Katzenstein TL...
https://www.dovepress.com/living-with-cystic-fibrosis-a-qualitative-study-of-a-life-coaching-int-peer-reviewed-article-PPA.  , 2018
Link: https://doaj.org/article..
 
?
14

Coach to cope: feasibility of a life coaching program for y..:

Knudsen KB ; Pressler T ; Mortensen LH...
https://www.dovepress.com/coach-to-cope-feasibility-of-a-life-coaching-program-for-young-adults--peer-reviewed-article-PPA.  , 2017
Link: https://doaj.org/article..
 
?
15

Soluble urokinase plasminogen activator receptor (suPAR) is..:

Rasmussen, LJH ; Knudsen, A ; Katzenstein, TL...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054925/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
1-15